DawMed Systems PLC
25 April 2008
25 April 2008
DAWMED SYSTEMS PLC
('Dawmed' or 'the Company')
AGM STATEMENT
Strong Q2 Trading Performance
Several High Value Tenders Secured
At today's Annual General Meeting of Dawmed, the medical devices company which
designs, manufactures, sells, distributes and services healthcare
decontamination equipment used by Secondary Care NHS Trust hospitals, private
hospitals and Primary Care practitioners and clinics, which is to be held later
today, the Executive Chairman, Kevin Gilmore, will provide the following update:
'Although it is less than a month since your Company's Annual Report and
Accounts were distributed to all shareholders, I am pleased to present a trading
update relating to the first two quarters of the current financial year as
follows:-
KEY POINTS:
• Several high value tenders won, including the ground breaking turnkey pr
oject at East Kent Hospitals;
• Overall historic level of sales substantially more buoyant than the
equivalent period last year;
• Abundance of activity in quoting and tendering for more new orders;
• Performance of sales of Wassenburg equipment particularly strong;
• Chemical sales substantially up and continuing to rise;
• New distributorship appointment for new top quality product; and
• New export distributor in Europe close to appointment.
It is pleasing for me to report that the first half of the current financial
year appears to have exceeded the Board's expectations, with the substantially
increased turnover achieved and the degree of recovery from the disappointing
effects of last year's industry sector unprecedented spending slowdown, which
led to the consequential and unprecedented loss suffered by your Company last
year.
So far as the UK is concerned, there can be no doubt that, although a more
normal level of NHS business appears to have been resumed, it is your Company's
amended strategy that has been largely responsible for its considerable success
in recent months and hopefully for the continuation of that success during the
second half of this year.
As part of your Company's efforts to increase the penetration into Europe of
export sales, not least to escape the partial dependence upon the NHS, your
Company has recently instigated a new offensive to appoint further distributors
for its products in the foreseeable future. In particular, the Company is close
to the first such appointment which it hopes to be in a position to detail to
shareholders in due course.
I am also pleased to announce that the Company has been appointed as exclusive
distributor for Meiko bed pan washer machines in England, Scotland and Wales,
thereby adding a further top quality product to the Company's portfolio.'
--ENDS--
Enquiries:
Dawmed Systems plc Tel: 01608 682244
Kevin Gilmore, Executive Chairman
Beaumont Cornish Limited Tel: 020 7628 3396
Roland Cornish
Bishopsgate Communications Limited Tel: 020 7562 3350
Dominic Barretto
For further information please visit Dawmed's website at www.dawmedsystems.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.